Name | Walgreens #11734 |
---|---|
Organization Name | Walgreen Co |
Location | 1315 N State St, Provo, Utah 84604 |
Type | Community/Retail Pharmacy |
Phone | (801) 616-5223 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Up to now, the brain's magnetic field is measurable only under technical laboratory conditions. This technique is therefore not feasible in terms of the broader medical use, although it would be significant for diagnosing numerous conditions such as epilepsy and dementia, or even for improving therapies such as deep brain stimulation for treating Parkinson's disease.
Use of computed tomography (CT) scans of the chest for hospital emergency-room patients with blunt trauma could be reduced by more than one-third without compromising detection of major injury, concludes a new study led by a UC San Francisco physician.
Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.
› Verified 2 days ago
NPI Number | 1578831699 |
Organization Name | WALGREENS |
Doing Business As | WALGREENS |
Type | Community/Retail Pharmacy |
Address | 1315 N State St, Provo, UT 84604 |
Phone Number | 801-616-5223 |
News Archive
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Up to now, the brain's magnetic field is measurable only under technical laboratory conditions. This technique is therefore not feasible in terms of the broader medical use, although it would be significant for diagnosing numerous conditions such as epilepsy and dementia, or even for improving therapies such as deep brain stimulation for treating Parkinson's disease.
Use of computed tomography (CT) scans of the chest for hospital emergency-room patients with blunt trauma could be reduced by more than one-third without compromising detection of major injury, concludes a new study led by a UC San Francisco physician.
Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.
› Verified 2 days ago
NPI Number | 1689849606 |
Organization Name | WALGREEN CO |
Doing Business As | WALGREENS #11734 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 1315 N State St, Provo, UT 84604 |
Phone Number | 801-616-5223 |
News Archive
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Up to now, the brain's magnetic field is measurable only under technical laboratory conditions. This technique is therefore not feasible in terms of the broader medical use, although it would be significant for diagnosing numerous conditions such as epilepsy and dementia, or even for improving therapies such as deep brain stimulation for treating Parkinson's disease.
Use of computed tomography (CT) scans of the chest for hospital emergency-room patients with blunt trauma could be reduced by more than one-third without compromising detection of major injury, concludes a new study led by a UC San Francisco physician.
Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.
› Verified 2 days ago
News Archive
Emerson Resources, Inc., a premier pharmaceutical solutions company, today announced that it has formed a strategic partnership with Bio Research, a contract research organization that specializes in the agrichemical and related industries, to further extend its business development capabilities. The exclusive partnership leverages the expertise of industry veteran Robert Westbrook, CEO of Bio Research, who is spearheading Emerson Resources' intensified business development and sales efforts.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
Up to now, the brain's magnetic field is measurable only under technical laboratory conditions. This technique is therefore not feasible in terms of the broader medical use, although it would be significant for diagnosing numerous conditions such as epilepsy and dementia, or even for improving therapies such as deep brain stimulation for treating Parkinson's disease.
Use of computed tomography (CT) scans of the chest for hospital emergency-room patients with blunt trauma could be reduced by more than one-third without compromising detection of major injury, concludes a new study led by a UC San Francisco physician.
Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.
› Verified 2 days ago
Alpine Home Medical Equipment Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 1481 N State St, Provo, Utah 84604 Phone: (801) 852-0077 | |
Excel Optical Type: Eyewear Supplier (Equipment, not the service) Location: 1735 N State St, Provo, Utah 84604 Phone: (801) 374-1818 | |
Intermountain Homecare Type: Medicare Supplier Location: 289w 1230 N, Provo, Utah 84604 Phone: (801) 357-8250 | |
Northwest Orthoticsprosthetics Inc Type: DME Supplier - Customized Equipment Location: 1675 N Freedom Blvd, Provo, Utah 84604 Phone: (801) 377-3433 | |